About Matthew M. Holub
Matt focuses his practice on resolving intellectual property disputes in the pharmaceutical industry. He primarily focuses on complex patent litigation involving the Hatch-Waxman Act and abbreviated new drug applications. He also uses his litigation experience to advise clients in complex commercial disputes involving antitrust, contract and tort claims, both within and beyond the pharmaceutical industry.
Working relentlessly to protect your investment
Before becoming an attorney, Matt worked for several years in the pharmaceutical industry, where he concentrated on brand identity and regulatory compliance of promotional activity. Now he leverages that experience to help his clients achieve their business goals through directed and focused counseling.
Matt works with his clients to meet their individual business needs. Those needs are often addressed through pre-dispute counseling, alternative dispute resolution tactics and settlement. His goal is to help clients reach beneficial resolutions as efficiently as possible, which has made him an integral part of settlement teams that have successfully resolved multimillion-dollar litigations. Matt also has extensive experience in all stages of trial and appellate practice, including pre-suit investigations, pleadings, e-discovery, expert discovery, motion practice, trial, appellate briefing and oral argument.
Matt's client advocacy shines through his pro bono work, which focuses on immigration cases involving asylum applicants. His victories successfully securing asylum for refugees fleeing persecution in their homelands are a testament to both his advocacy and trial skills.
- Intellectual property
- Patent litigation
- Pharmaceutical and life sciences litigation
- Commercial litigation
Katten Assists in Farasis Energy's Restructuring, Listing on SSE STAR Market and Its Strategic Cooperation With DaimlerJuly 20, 2020
January 29, 2020
January 25, 2018
American Bar Association Recognizes Katten's Pro Bono Publico Award With Ceremony and Highlights VideoAugust 8, 2016
June 15, 2016
November 19, 2014
Supreme Court Rules Patent Claims Ineligible as Abstract Ideas, Affirming Federal Circuit in Alice Corp Pty. Ltd. v. CLS Bank Int'lJune 19, 2014